Pipeline

Overview

Ocera’s pipeline consists of two compounds targeting acute and chronic liver disease as well as various gastrointestinal disorders.

	Pre-clinical	Phase 1	Phase 2	Phase 3
Acute Hepatic Encephalopathy in Liver Cirrhosis
OCR-002 (IV)
Acute Hepatic Encephalopathy in Acute Liver Failure
OCR-002 (IV)
Chronic Treatment and Prevention of HE
OCR-002 (Oral)
Irritable Bowel Syndrome (non constipating)
AST-120
Pouchitis
AST-120
Mild Hepatic Encephalopathy
AST-120